Inventor
WITTMAN MARK D
US34 patents
⚠️ This page may combine multiple inventors who share the name “WITTMAN MARK D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
26 patentsUS5646176AJul 8, 1997
Phosphonooxymethyl ethers of taxane derivatives
BRISTOL MYERS SQUIBB CO104 citations97
US5912264AJun 15, 1999
6-halo-or nitrate-substituted paclitaxels
BRISTOL MYERS SQUIBB CO81 citations96
US5489589AFeb 6, 1996
Amino acid derivatives of paclitaxel
BRISTOL MYERS SQUIBB CO54 citations96
US7534792B2May 19, 2009
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO30 citations92
US5478854ADec 26, 1995
Deoxy taxols
BRISTOL MYERS SQUIBB CO39 citations92
US7223757B2May 29, 2007
Tyrosine kinase inhibitors
BRISTOL MYERS SQUIBB CO16 citations91
US5773461AJun 30, 1998
7-deoxy-6-substituted paclitaxels
BRISTOL MYERS SQUIBB CO25 citations89
US7232826B2Jun 19, 2007
Tyrosine kinase inhibitors
BRISTOL MYERS SQUIBB CO13 citations84
US7879855B2Feb 1, 2011
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO10 citations83
US9556179B2Jan 31, 2017
Substituted imidazoles as casein kinase 1 D/E inhibitors
BRISTOL MYERS SQUIBB CO9 citations81
US6455575B2Sep 24, 2002
Phosphonooxymethyl ethers of taxane derivatives
BRISTOL MYERS SQUIBB CO7 citations73
US5395849AMar 7, 1995
Hybrid antitumor compounds containing a cyclic enediyne and a DNA-binder
BRISTOL MYERS SQUIBB CO19 citations73
US7081454B2Jul 25, 2006
Tyrosine kinase inhibitors
BRISTOL MYERS SQUIBB CO6 citations72
US6362217B2Mar 26, 2002
Taxane anticancer agents
BRISTOL MYERS SQUIBB CO7 citations67
US6201140B1Mar 13, 2001
7-0-ethers of taxane derivatives
BRISTOL MYERS SQUIBB CO5 citations63
US7189716B2Mar 13, 2007
Tyrosine kinase inhibitors
BRISTOL MYERS SQUIBB CO4 citations62
US11166959B2Nov 9, 2021
Isofuranone compounds useful as HPK1 inhibitors
BRISTOL MYERS SQUIBB CO1 citations59
US5977386ANov 2, 1999
6-thio-substituted paclitaxels
BRISTOL MYERS SQUIBB CO5 citations57
US5318989AJun 7, 1994
Cytotoxic bicyclo [7.3.1.]tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
BRISTOL MYERS SQUIBB CO0 citations52
US8343999B2Jan 1, 2013
Thiazolyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US7470696B2Dec 30, 2008
Tyrosine kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US9475817B2Oct 25, 2016
Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors
BRISTOL MYERS SQUIBB CO1 citations50
US9598423B2Mar 21, 2017
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
BRISTOL MYERS SQUIBB CO0 citations45
US9273058B2Mar 1, 2016
Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors
BRISTOL MYERS SQUIBB CO1 citations45
US7312215B2Dec 25, 2007
Benzimidazole C-2 heterocycles as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations40
US9956220B2May 1, 2018
Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors
BRISTOL MYERS SQUIBB CO0 citations34